Viewing Study NCT02860611



Ignite Creation Date: 2024-05-06 @ 8:58 AM
Last Modification Date: 2024-10-26 @ 12:07 PM
Study NCT ID: NCT02860611
Status: COMPLETED
Last Update Posted: 2016-08-09
First Post: 2016-08-04

Brief Title: Comparison of Th1 Cytokine Levels Between Type 1 and Type 2 Diabetes
Sponsor: Istanbul Medeniyet University
Organization: Istanbul Medeniyet University

Study Overview

Official Title: Comparison of Th1 Cytokine Levels Between Type 1 and Type 2 Diabetes
Status: COMPLETED
Status Verified Date: 2016-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Recent reports show increased prevalence of obesity in patients with type 1 diabetes T1DPs while some studies stated that patients with type 2 diabetes T2DPs have islet cell auto-antibodies These results raise the question of a common pathway in T1DM and T2DM via an association with T helper cells In this study investigators aimed to investigate the difference between T helper 1 Th1 cytokines levels in T1DPs T2DPs and healthy subjects

The study included 114 T1DPs on insulin treatment 35 newly diagnosed T2DPs who had not used oral antidiabetics but insulin before and 31 healthy subjects CG

Serum interferon gamma IFN-γ interleukin-2 IL-2 and tumor necrosis factor alpha TNF-α levels were measured using ELISA method Serum levels of those cytokines in T1DPs were compared with those in T2DPs and controls
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None